Aquestive Therapeutics, Inc.
NASDAQ:AQST
3.52 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -7.87 | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 | -8.943 | -9.602 |
| Depreciation & Amortization
| 1.345 | 2.387 | 2.964 | 3.443 | 2.905 | 3.236 | 3.801 | 3.891 |
| Deferred Income Tax
| 0 | 0 | 13.822 | 0 | 4.896 | 5.281 | 0 | 0 |
| Stock Based Compensation
| 2.689 | 4.381 | 6.819 | 6.581 | 7.071 | 29.94 | 0 | 0 |
| Change In Working Capital
| -5.341 | 32.007 | -1.73 | -4.413 | -11.124 | 7.998 | 7.881 | -6.293 |
| Accounts Receivables
| -3.073 | 7.352 | -4.939 | 1.202 | -7.435 | -0.409 | 4.691 | -6.508 |
| Inventory
| -0.989 | -1.743 | -1.577 | 0.398 | 2.582 | -1.427 | -1.128 | -1.587 |
| Accounts Payables
| -1.02 | 1.633 | 1.225 | -5.185 | -7.872 | 11.319 | 2.943 | 1.65 |
| Other Working Capital
| -0.259 | 24.765 | 3.561 | -0.828 | 1.601 | -1.485 | 1.375 | 0.152 |
| Other Non Cash Items
| 2.797 | 5.846 | 15.685 | 4.713 | 2.288 | 1.93 | 3.085 | 3.829 |
| Operating Cash Flow
| -6.38 | -9.789 | -32.979 | -45.459 | -60.21 | -12.991 | 5.824 | -8.175 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -0.995 | -2.524 | -0.913 | -0.517 | -0.663 | -1.824 | -2.068 | -0.976 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.166 |
| Other Investing Activites
| 0 | -1.5 | 0 | 0 | 0 | 0 | 0 | 1.166 |
| Investing Cash Flow
| -0.995 | -2.524 | -0.913 | -0.517 | -0.663 | -1.824 | -2.068 | 0.19 |
| Financing Activities: | ||||||||
| Debt Repayment
| -20.385 | 0 | 0 | -22.5 | 17.056 | 0 | 5 | 6.937 |
| Common Stock Issued
| 8.912 | 13.586 | 29.78 | 6.215 | 39.317 | 68.83 | 0.024 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 15.447 | -2.024 | 0.329 | 44.742 | -6.773 | -10.795 | -0.586 | -1.248 |
| Financing Cash Flow
| 3.974 | 11.562 | 30.109 | 28.457 | 49.6 | 58.035 | 4.414 | 5.689 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -3.401 | -0.751 | -3.783 | -17.519 | -11.273 | 43.22 | 8.17 | -2.296 |
| Cash At End Of Period
| 23.872 | 27.273 | 28.024 | 31.807 | 49.326 | 60.599 | 17.379 | 9.209 |